Abstract
Introduction

44
Maximal oxygen uptake (̇O2max), typically expressed in relation to a measure of body 30, 32), with the reasons behind this still being unclear, the term ̇O 2peak is routinely used 53 to denote the highest ̇O 2 recorded without a plateau (1). Secondary objective criteria 54 (e.g. respiratory exchange ratio (RER) and maximal heart rate (HRmax) thresholds) (3, 33) 55 are therefore often used to verify that the ̇O 2peak attained was a "true" ̇O 2max for children 56 and adolescents but significantly underestimate ̇O 2max (5). While, the validity of 57 secondary objective criteria has recently been challenged (5, 26), their use is still 58 commonplace in contemporary pediatric research (e.g. 15, 28).
59
To overcome the validity issues with the primary and secondary criteria, the 1990s saw 60 the emergence of a supramaximal test to verify that the ̇O 2peak that had been achieved in 61 the incremental test is a "true" ̇O 2max. This requires participants to exercise at a power 62 output greater than the maximal power output achieved during the incremental test (3, 33) 63 and is a variation of the original protocol proposed by Taylor et al. (36) . However, the 64 supramaximal verification tests were initially conducted on separate days (3, 33), which may not be feasible, due to logistical requirements of supplementary laboratory visits.
66
Recently, it has been shown that children can successfully perform the supramaximal 67 verification test on the same day as the incremental test, following a short rest of 10-15 68 min following the incremental test (5, 7, 31), and is now the recommended protocol for 69 ̇O 2max determination (6, 27). as ̇O 2max testing is conducted on an individual basis. The effect of body mass status on 85 the verification of ̇O 2max using supramaximal exercise has only been studied by 86 Bhammar et al. (7) who found both obese (n = 9) and non-obese (n = 9) children to have 
99
The purpose of the current study was to extend previous work in this area (5) and further 100 examine the validity of testing procedures to determine ̇O 2max in a large sample of 101 healthy children and adolescents. Specifically, our aims were to: 1) examine whether the 102 validity of the supramaximal verification test differs in children and adolescents when 103 stratified for sex, body mass and CRF status; and 2) assess the sensitivity and specificity 104 of primary (i.e. plateau) and secondary (i.e. RER and HR thresholds) objective criteria to 105 verify the ̇O 2peak attained in the incremental test as ̇O 2max when compared to a 106 supramaximal confirmed ̇O 2max measurement.
107
Methods
108
Participants:
109
Existing data from our laboratory were pooled and retrospectively analysed to produce a 110 sample of 128 healthy children and adolescents. Only data from 13 participants that form 111 the final sample have previously been published elsewhere to examine the validity of the supramaximal test (5). All data were collected as part of studies which originally were 113 granted ethics approval by institutional and NHS ethics committees (where relevant).
114
Inclusion criteria for this study were: 1) 8-<18 years old and; 2) ̇O 2max assessed using a 115 combined incremental and supramaximal test protocol, conducted on the same day; 3) 116 ostensibly healthy participants and; 4) cycling modality. All children and their parent(s) 117 or guardian(s) gave informed assent and consent, respectively, to participate in the 118 original studies. Body mass index (BMI) was calculated, and age-appropriate criteria were used to classify 123 participants into non-overweight and overweight/obese categories (12). Maturity
124
(somatic) offset from the age of peak height velocity (APHV) was calculated through the 125 equations by Moore et al. (21) , which have been validated in two external samples where 126 90% of predictions are within ± 1 year. Pre-peak height velocity (PHV) children were 127 defined as >-1 year from PHV, circa-PHV children were -1 to 1 year from PHV and post-128 PHV children were >1 year from PHV.
129
Incremental and supramaximal test protocols:
130
A combined incremental-ramp and supramaximal test to exhaustion was used to The measurement of ̇O 2peak from the ramp-incremental test to exhaustion has a 146 coefficient of variation of 4.1% (37).
147
Gas collection and analysis:
148
Pulmonary gas exchange and heart rate (HR) were measured using online systems (Cortex were log transformed when the normality assumption was violated. Independent t-tests were also used to calculate the area under the curve (AUC). There were no differences in the proportion of plateau observations during the 268 incremental test between males and females (29%; n = 22 vs. 25%; n = 13; P=0.62).
269
̇O 2max between males and females (89%; n = 68 vs. 85%; n = 44; P=0.41).
271
The 
393
(31) who found no significant difference between tests for either sex. This could be 394 because of their much lower sample size, providing lower statistical power to detect small 395 differences. However, although the differences were significant, effect sizes showed this high fit individuals (4 low fit participants vs. 1 moderate/high fit participant respectively).
412
In contrast, we found no significant differences between the different levels of CRF 
423
It has been noted that the manipulation of recovery period and its effect on ̇O 2max 424 verification using the supramaximal test is an under researched area (35), and to our 425 knowledge this is the first study to examine this concept in a pediatric group. Whilst it
426
was not a systematically manipulated outcome, the rest period between the incremental 427 and supramaximal test was not a significant predictor of ̇O 2max verification in the 428 supramaximal test suggesting there is no effect of the duration of recovery on the 429 measurement of ̇O 2max in a healthy pediatric population.
430
The low plateau attainment in the incremental test in this study (27%) 
